AKT1 and prostate carcinoma: In prostate cancer patients, AKT expression and phosphorylation were significantly associated to unfavorable outcome, with cytosolic AKT1 expression correlated with a higher risk of postoperative recurrence53 and pAKT levels predictive of poor clinical outcome4.